These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients. Plaza G; Santón A; Vidal AM; Bellas C Acta Otolaryngol; 2003 Jun; 123(5):664-8. PubMed ID: 12875592 [TBL] [Abstract][Full Text] [Related]
30. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559 [TBL] [Abstract][Full Text] [Related]
31. Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and epstein-barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma. Hao SP; Tsang NM; Chang KP Laryngoscope; 2004 Nov; 114(11):2027-30. PubMed ID: 15510036 [TBL] [Abstract][Full Text] [Related]
32. Nasopharyngeal carcinoma derived exosomes regulate the proliferation and migration of nasopharyngeal carcinoma cells by mediating the miR-99a-5p BAZ2A axis. Zhou XJ; Xu HM; Huang GS; Lin BR Braz J Otorhinolaryngol; 2024; 90(1):101343. PubMed ID: 37925811 [TBL] [Abstract][Full Text] [Related]
33. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. Du ZM; Hu LF; Wang HY; Yan LX; Zeng YX; Shao JY; Ernberg I PLoS One; 2011 Apr; 6(4):e19137. PubMed ID: 21541331 [TBL] [Abstract][Full Text] [Related]
34. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients. Dardari R; Khyatti M; Cordeiro P; Odda M; ElGueddari B; Hassar M; Menezes J Int J Cancer; 2006 Apr; 118(8):1977-83. PubMed ID: 16287066 [TBL] [Abstract][Full Text] [Related]
35. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Lei T; Yuen KS; Xu R; Tsao SW; Chen H; Li M; Kok KH; Jin DY Int J Cancer; 2013 Jul; 133(1):79-87. PubMed ID: 23280823 [TBL] [Abstract][Full Text] [Related]
36. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections. Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781 [TBL] [Abstract][Full Text] [Related]
37. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Lung RW; Tong JH; Sung YM; Leung PS; Ng DC; Chau SL; Chan AW; Ng EK; Lo KW; To KF Neoplasia; 2009 Nov; 11(11):1174-84. PubMed ID: 19881953 [TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma. Gao W; Li ZH; Chen S; Chan JY; Yin M; Zhang MJ; Wong TS Oncotarget; 2017 Mar; 8(12):20297-20308. PubMed ID: 28423621 [TBL] [Abstract][Full Text] [Related]
39. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996 [TBL] [Abstract][Full Text] [Related]
40. [Effect of rAAV-mediated RNA interference against EB virus-encoded latent membrane protein 1 on nasopharyngeal carcinoma cell proliferation and metastasis in nude mice]. Liu X; Liu X; Li G; Zhang B; Wang L; Li XH; Li XP Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):611-4. PubMed ID: 19403376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]